pharma · Metastatic castration-resistant prostate cancer. · short-term treatment of insomnia
Orion Laboratories Pty
Orion Laboratories Pty.
Orion Laboratories Pty patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Baton Rouge, USA
- Founded
- 2008
- Employees
- 52
- Programs
- 9
- Drugs
- 20
- Patents
- 0
Orion Laboratories Pty patents
0 pharmaceutical patents indexed for Orion Laboratories Pty. 0 expire within 24 months.
Orion Laboratories Pty has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Orion Laboratories Pty have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Orion Laboratories Pty patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.